Envestnet Asset Management
BLFS icon

Envestnet Asset Management’s BioLife Solutions BLFS Stock Holding History

Envestnet Asset Management’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.56M Sell
161,457
-80,982
-33% -$1.89M ﹤0.01% 2529
2026
Q1 		$4.63M Buy
242,439
+18,517
+8% +$409K ﹤0.01% 2367
2025
Q4 		$5.41M Sell
223,922
-20,086
-8% -$526K ﹤0.01% 2123
2025
Q3 		$6.22M Sell
244,008
-4,185
-2% -$99.3K ﹤0.01% 2086
2025
Q2 		$5.35M Sell
248,193
-25,136
-9% -$567K ﹤0.01% 2155
2025
Q1 		$6.24M Buy
273,329
+74,634
+38% +$1.97M ﹤0.01% 1972
2024
Q4 		$5.16M Buy
198,695
+31,167
+19% +$776K ﹤0.01% 2080
2024
Q3 		$4.19M Buy
167,528
+40,313
+32% +$952K ﹤0.01% 2214
2024
Q2 		$2.73M Buy
127,215
+92,021
+261% +$1.79M ﹤0.01% 2423
2024
Q1 		$653K Buy
35,194
+8,136
+30% +$142K ﹤0.01% 3281
2023
Q4 		$440K Sell
27,058
-36,452
-57% -$465K ﹤0.01% 3399
2023
Q3 		$877K Buy
63,510
+28,444
+81% +$448K ﹤0.01% 2899
2023
Q2 		$775K Buy
35,066
+793
+2% +$16.7K ﹤0.01% 2950
2023
Q1 		$745K Sell
34,273
-7,423
-18% -$167K ﹤0.01% 2874
2022
Q4 		$759K Sell
41,696
-7,563
-15% -$156K ﹤0.01% 2838
2022
Q3 		$1.12M Buy
49,259
+1,003
+2% +$21.5K ﹤0.01% 2479
2022
Q2 		$666K Buy
48,256
+2,075
+4% +$30.4K ﹤0.01% 2888
2022
Q1 		$1.05M Buy
46,181
+11,374
+33% +$299K ﹤0.01% 2622
2021
Q4 		$1.3M Buy
34,807
+9,885
+40% +$424K ﹤0.01% 2452
2021
Q3 		$1.05M Buy
24,922
+11,215
+82% +$540K ﹤0.01% 2508
2021
Q2 		$610K Buy
13,707
+2,594
+23% +$91.4K ﹤0.01% 2849
2021
Q1 		$400K Buy
+11,113
New +$439K ﹤0.01% 2976

Other funds holding BLFS

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Envestnet Asset Management's BLFS Position: Q2 2026 in Review

Envestnet Asset Management reduced its BioLife Solutions (BLFS) stake by 33% in Q2 2026, selling an estimated $1.89M and leaving 161,457 shares worth $4.56M. The position accounts for ﹤0.01% of the portfolio, ranked #2529.

Envestnet Asset Management first reported a position in BLFS in Q1 2021 and has held it in 22 quarters since. The position peaked at $6.24M in Q1 2025. 216 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

  • Envestnet Asset Management held 161,457 shares of BioLife Solutions worth $4.56M as of Q2 2026.
  • Envestnet Asset Management sold 80,982 BioLife Solutions shares in Q2 2026, an estimated $1.89M.
  • BioLife Solutions made up ﹤0.01% of Envestnet Asset Management's portfolio in Q2 2026, its #2529 holding.
  • Envestnet Asset Management first reported a position in BioLife Solutions in Q1 2021 and has held it in 22 quarters since.
  • Envestnet Asset Management's BioLife Solutions position peaked at $6.24M in Q1 2025.
  • 216 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.